In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

IsoTis buys GenSci OrthoBiologics

Executive Summary

IsoTis SA, a biosurgery firm created in 2002 through the merger of Swiss biotech Modex Therapeutics and Dutch biomedical company IsoTis, is acquiring GenSci OrthoBiologics, the subsidiary of Canadian orthobiologics company GenSci Regeneration Sciences through a stock transaction. The merged entity will be called IsoTis OrthoBiologics.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
  • Medical Devices
    • Biomaterials
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Intra-Biotech Deal
    • Payment Includes Stock

Related Companies